Since, in CRCs, FGFR4 mediates cancer progression via phosphorylation of STAT3 [38], we assessed its phosphorylation status at the Y705 site in CRC cells after TRIP13 shRNA knockdown and treatment with DCZ0415. Here, STAT3 is linked to cancer.